Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy.
Journal: Science translational medicine
Published: January 15, 2025
Insights from new in vivo models of TREM2 variants.
Journal: Molecular neurodegeneration
Published: February 16, 2023
Testing for Allele-specific Expression from Human Brain Samples.
Journal: Bio-protocol
Published: January 28, 2023
ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy.
Journal: Science (New York, N.Y.)
Published: January 12, 2023
APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints.
Journal: Nature immunology
Published: November 03, 2022
TREM2 and microglia exosomes: a potential highway for pathological tau.
Journal: Molecular neurodegeneration
Published: October 21, 2022
GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
Journal: Science (New York, N.Y.)
Published: August 18, 2022
TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4.
Journal: Neuron
Published: June 21, 2022
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading.
Journal: The Journal of experimental medicine
Published: April 13, 2022
Activated microglia mitigate Aβ-associated tau seeding and spreading.
Journal: The Journal of experimental medicine
Published: March 06, 2021
TREM2 function impedes tau seeding in neuritic plaques.
Journal: Nature neuroscience
Published: March 01, 2019
Genetic Modifiers in Neurodegeneration.
Journal: Current genetic medicine reports
Published: July 07, 2018
Last Updated: 09/26/2026